OSX/SP7 Mutations and Osteogenesis Imperfecta - Osteogenesis Imperfecta - page 163

[31] Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS,

Albright S, et al. Mutations involving the transcription factor
CBFA1 cause cleidocranial dysplasia. Cell 1997;89:773-9.

[38] Rivadeneira F, Styrkarsdottir U, Estrada K, Halldorsson BV, Hsu

YH, Richards JB, et al. Twenty bone-mineral-density loci iden-
tiied by large-scale meta-analysis of genome-wide association
studies. Nat Genet 2009;41:1199-206. [32] Baek WY, de Crombrugghe B, Kim JE. Postnatally induced inac-

tivation of Osterix in osteoblasts results in the reduction of bone
formation and maintenance. Bone 2010;46:920-8.

[39] Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson

DF, Walters GB, Ingvarsson T, et al. New sequence variants asso-
ciated with bone mineral density. Nat Genet 2009;41:15-17. [33] Choi YH, Gu YM, Oh JW, Lee KY. Osterix is regulated by

Erk1/2 during osteoblast differentiation. Biochem Biophys Res
Commun 2011;415:472-8.

[40] Timpson NJ, Tobias JH, Richards JB, Soranzo N, Duncan EL, Sims

AM, et al. Common variants in the region around Osterix are asso-
ciated with bone mineral density and growth in childhood. Hum
Mol Genet 2009;18:1510-7.

[34] Koga T, Matsui Y, Asagiri M, Kodama T, de Crombrugghe B,

Nakashima K, et al. NFAT and Osterix cooperatively regulate
bone formation. Nature Med 2005;11:880-5. [41] Jin H, van't Hof RJ, Albagha OME, Ralston SH. Promoter and

intron 1 polymorphisms of COL1A1 interact to regulate transcrip-
tion and susceptibility to osteoporosis. Hum Molec Genet 2009;
18:2729-38.

[35] Goto T, Matsui Y, Fernandes RJ, Hanson DA, Kubo T, Yukata K,

et al. Sp1 family of transcription factors regulates the human
alpha2 (XI) collagen gene (COL11A2) in Saos-2 osteoblastic cells. J
Bone Miner Res 2006;21:661-73. [42] Niger C, Lima F, Yoo DJ, Gupta RR, Buo AM, Hebert C, Stains JP.

The transcriptional activity of osterix requires the recruitment of
Sp1 to the osteocalcin proximal promoter. Bone 2011;49:683-92.

[36] Ali MM, Yoshizawa T, Ishibashi O, Matsuda A, Ikegame M,

Shimomura J, et al. PIASxbeta is a key regulator of osterix tran-
scriptional activity and matrix mineralization in osteoblasts. J Cell
Sci 2007;120:2565-73.

[37] Ulsamer A, Ortuño MJ, Ruiz S, Susperregui AR, Osses N, Rosa JL,

et al. BMP-2 induces Osterix expression through up-regulation of
Dlx5 and its phosphorylation by p38. J Biol Chem 2008;283:3816-26.